Clinical trial
Evaluation of the Safety and Clinical Efficacy of Hydroxychloroquine Associated With Azithromycin in Patients With Pneumonia Caused by Infection by the SARS-CoV2 Virus - Coalition COVID-19 Brasil II - SEVERE - Patients
NCT04321278 is registered in ClinicalTrials.gov with Hospital Israelita Albert Einstein as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Safety and Clinical Efficacy of Hydroxychloroquine Associated With Azithromycin in Patients With Pneumonia Caused by Infection by the SARS-CoV2 Virus - Coalition COVID-19 Brasil II - SEVERE - Patients
- Lead sponsor
- Hospital Israelita Albert Einstein
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 28, 2020
- Completion date
- June 14, 2020
- Enrollment
- 440 (actual)
- Sites
- 58
Conditions
As the registry lists them; a condition with its own page is linked.